Related Experiment Video
Updated: Sep 8, 2025

09:25
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
Published on: June 28, 2013
27.1K
Form Follows Function: A New Paradigm of Pancreatic Cancer Progression.
Biorxiv : the Preprint Server for Biology
|August 20, 2025
Summary
Pancreatic cancer invades nearby tissues by adopting specific geometric shapes. AI analysis of H&E images reveals these tumor structures correlate with aggressive molecular features and patient outcomes.
Area of Science:
- Oncology
- Computational Pathology
- Cancer Biology
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is known for its aggressive local invasion and vascular infiltration, yet the underlying mechanisms remain unclear.
- Understanding the link between molecular alterations and the physical behavior of PDAC is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the spatial and geometric properties of PDAC tumor structures and their correlation with invasiveness and molecular subtypes.
- To develop and validate an AI-assisted computational tool for analyzing tumor morphology and predicting clinical behavior.
Main Methods:
- Development of a large-scale, AI-assisted PDAC atlas from H&E images, annotating over 144,000 structures.
- Creation of the SHAPE computational tool for geometrizing cancer progression and analyzing morphology.
- Integration of morphological data with whole-genome, RNA sequencing, and spatial transcriptomic data from PDAC patients.
Main Results:
- Invading PDAC structures exhibit eccentric morphology and local angular coherence, closely tracking vessels and nerves.
- Eccentric structures correlate with increased copy number alterations, loss of heterozygosity on chromosome 17p, and a quasi-mesenchymal/basal-like molecular subtype.
- Upregulation of invasive programs like EMT, angiogenesis, and coagulation pathways was confirmed in eccentric structures via spatial transcriptomics.
Conclusions:
- PDAC exhibits a distinct tumor architecture characterized by specific geometric and spatial properties linked to its aggressive behavior.
- AI-driven morphological analysis offers a powerful, interpretable approach to assess PDAC aggressiveness, predict treatment response, and guide clinical management.
Related Concept Videos
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K

